What are the antibiotics (atb) for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Cellulitis

First-Line Treatment

For typical non-purulent cellulitis, start with oral antibiotics targeting beta-hemolytic streptococci—specifically penicillin, amoxicillin, dicloxacillin, or cephalexin for 5 days. 1, 2

The pathogen driving most cellulitis cases is beta-hemolytic streptococci, not Staphylococcus aureus, unless there's penetrating trauma or an underlying abscess. 1, 3 This is why streptococcal coverage alone is sufficient for most cases.

Specific Antibiotic Options:

  • Penicillin 1
  • Amoxicillin 1, 2
  • Dicloxacillin 1, 2
  • Cephalexin 1, 2, 3

For Penicillin-Allergic Patients:

  • Clindamycin 1, 2
  • Erythromycin 1, 2
  • Levofloxacin (reserve for true beta-lactam allergies) 1, 2

Treatment Duration

Treat for 5 days initially, extending only if no improvement is seen. 1, 2 The American College of Physicians specifically recommends this 5-day course for non-purulent cellulitis. 1, 2 Research confirms that courses longer than 5 days provide no additional benefit for uncomplicated cases. 4

For severe or complicated cellulitis requiring hospitalization, extend to 7-14 days based on clinical response. 1, 2

When to Add MRSA Coverage

Add empiric MRSA coverage only for purulent cellulitis or specific high-risk features. 1, 2

Indications for MRSA Coverage:

  • Purulent drainage or exudate without a drainable abscess 1
  • Penetrating trauma 1, 2
  • Evidence of MRSA infection elsewhere 1, 2
  • Nasal MRSA colonization 1, 2
  • Injection drug use 1, 2
  • Systemic inflammatory response syndrome (SIRS) 1, 2

MRSA-Active Antibiotic Options:

  • Clindamycin (covers both streptococci and MRSA) 1, 2
  • Trimethoprim-sulfamethoxazole (must add a beta-lactam like amoxicillin for streptococcal coverage) 1, 2
  • Tetracyclines (must add a beta-lactam for streptococcal coverage) 1, 2
  • Linezolid (covers both streptococci and MRSA) 1, 2

Important Caveat on MRSA Coverage:

Despite high community-acquired MRSA prevalence in some regions, adding trimethoprim-sulfamethoxazole to cephalexin for non-purulent cellulitis showed no benefit in a randomized controlled trial. 5 National guidelines do not recommend routine MRSA coverage for typical non-purulent cellulitis. 3, 5 However, in areas with very high MRSA prevalence (like Hawaii with 62% MRSA isolation rates), antibiotics with MRSA activity showed significantly higher success rates. 6

Severe Cellulitis Requiring Hospitalization

For hospitalized patients, use IV vancomycin or linezolid for empiric MRSA coverage pending cultures. 2

For severely compromised patients, consider vancomycin plus piperacillin-tazobactam or a carbapenem (imipenem/meropenem) for broader coverage. 2

Adjunctive Measures

Elevate the affected extremity to promote drainage of edema and inflammatory substances. 1, 2 This is critical—failure to elevate delays improvement. 1, 2

Examine and treat interdigital toe web spaces for tinea pedis, fissuring, scaling, or maceration, as these harbor pathogens and predispose to recurrent cellulitis. 1, 2

Consider adding prednisone 40 mg daily for 7 days in non-diabetic adults to hasten resolution. 1, 2

Common Pitfalls to Avoid

  • Not examining toe web spaces—this is a frequent portal of entry for pathogens 1, 2
  • Failing to elevate the affected area—this significantly delays improvement 1, 2
  • Stopping antibiotics at 5 days when there's no improvement—extend treatment duration in these cases 1, 2
  • Routinely adding MRSA coverage for non-purulent cellulitis—this is unnecessary and promotes resistance 3, 5
  • Obtaining blood cultures in typical cases—these are low-yield and not recommended unless there are severe systemic features, malignancy, or unusual predisposing factors 2

References

Guideline

First-Line Antibiotic Treatment for Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cellulitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.